Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophia Myotonica”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05323955
What this trial is testing

Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib

Who this might be right for
Brain MetastasesHuman Epidermal Growth Factor 2 Positive Carcinoma of BreastAdvanced Breast Cancer
Carey Anders, M.D. 48
Not applicableStudy completedNCT05865483
What this trial is testing

Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)

Who this might be right for
Myotonic Dystrophy 1Dysphagia, Oropharyngeal
University College, London 177
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481879
What this trial is testing

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Dyne Therapeutics 127
Large-scale testing (Phase 3)UnknownNCT05755048
What this trial is testing

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 314
Not applicableEnded earlyNCT02930408
What this trial is testing

Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects

Who this might be right for
Steinert's Disease
Poitiers University Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT07587242
What this trial is testing

Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

Who this might be right for
Muscular DystrophiesMuscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)Muscular Disorders, Atrophic+11 more
Avidity Biosciences, Inc. 70
Not applicableStudy completedNCT06331429
What this trial is testing

Emoticare: Serious Game for the Adaptation to the Disease of Adolescents With Type 1 Diabetes Mellitus.

Who this might be right for
Type 1 DiabetesAdolescent Development
University of Valencia 200
Not applicableLooking for participantsNCT06708468
What this trial is testing

Personalized Training for People With Rare Neuromuscular Disorders

Who this might be right for
Neuromuscular Diseases (NMD)Charcot Marie Tooth Disease (CMT)Facioscapulohumeral Muscular Dystrophy+1 more
Oslo University Hospital 120
Not applicableNo Longer AvailableNCT01120561
What this trial is testing

Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc.
Not applicableLooking for participantsNCT07415837
What this trial is testing

Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies

Who this might be right for
Duchenne / Becker Muscular DystrophyDystrophia Myotonica 1Congenital Myopathies+1 more
University Hospital, Clermont-Ferrand 104
Not applicableStudy completedNCT05036447
What this trial is testing

Myotonic Dystrophy Type 1 and Resistance Exercise

Who this might be right for
Myotonic Dystrophy 1
Norwegian School of Sport Sciences 21
Not applicableLooking for participantsNCT06075693
What this trial is testing

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Massachusetts General Hospital 88
Not applicableLooking for participantsNCT03981575
What this trial is testing

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Who this might be right for
Myotonic Dystrophy 1DM1
Virginia Commonwealth University 700
Not applicableStudy completedNCT05916677
What this trial is testing

Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Institut de Myologie, France 35
Large-scale testing (Phase 3)Looking for participantsNCT07673029
What this trial is testing

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
GeneQuantum Healthcare (Suzhou) Co., Ltd. 228
Not applicableActive Not RecruitingNCT05072288
What this trial is testing

A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Université du Québec à Chicoutimi 40
Large-scale testing (Phase 3)WithdrawnNCT04700046
What this trial is testing

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy Type 1 and Type 2
Lupin Ltd.
Early research (Phase 1)Study completedNCT02038010
What this trial is testing

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IIIA Breast Cancer+3 more
Northwestern University 17
Not applicableStudy completedNCT03059264
What this trial is testing

Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy

Who this might be right for
Congenital Myotonic Dystrophy
Virginia Commonwealth University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Next Page